Halozyme Therapeutics (HALO) EPS (Basic) (2010 - 2026)
Halozyme Therapeutics' EPS (Basic) was $1.96 in Q2 2026, up 44.0% from $1.36 a year earlier and up 54.4% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EPS (Basic) (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Halozyme Therapeutics' EPS (Basic) was $3.53 through Jun 30, 2026, down 23.2% year-over-year; for FY2025, it was $2.64, down 24.5% from FY2024.
- EPS (Basic) shows a five-year compound annual growth rate of 22.8% (FY2020 to FY2025).
- In earlier years, EPS (Basic) was $3.50 in FY2024 (+64.0%), $2.13 in FY2023 (+44.5%), $1.48 in FY2022 (-48.4%) and $2.86 in FY2021 (+202.1%).
- The Q2 2026 figure marks the highest quarterly EPS (Basic) in data going back to Q2 2010.
- The best year-over-year quarter for EPS (Basic) over five years was Q3 2021 (growth of 475.3%); the worst was Q2 2022 (a decline of 74.4%).
- Per Business Quant data, HALO's EPS (Basic) in the three quarters before Q2 2026 was $1.27 (Q1 2026), -$1.18 (Q4 2025) and $1.49 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,160.65 Bn | 1,129.23 Bn | 19.71 Bn | 7.95 |
| 2 | Johnson & Johnson | 633.19 Bn | 551.72 Bn | 17.26 Bn | 2.30 |
| 3 | AbbVie | 501.90 Bn | 475.01 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 377.07 Bn | 331.45 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 302.35 Bn | 266.34 Bn | 11.24 Bn | 1.68 |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 1.62 |
| 7 | Amgen | 240.68 Bn | 196.07 Bn | 7.24 Bn | 4.40 |
| 8 | Gilead Sciences | 193.20 Bn | 167.40 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | -0.04 |
| 10 | Halozyme Therapeutics | 14.50 Bn | 13.11 Bn | 401.83 Mn | 1.96 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 |
| Mar 31, 2026 | 1.27 |
| Dec 31, 2025 | -1.18 |
| Sep 30, 2025 | 1.49 |
| Jun 30, 2025 | 1.36 |
| Mar 31, 2025 | 0.96 |
| Dec 31, 2024 | 1.08 |
| Sep 30, 2024 | 1.08 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.61 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | 0.62 |
| Jun 30, 2023 | 0.57 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.42 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 1.53 |
API Access
Halozyme Therapeutics EPS (Basic) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-basic&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-basic", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-basic&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();